According to Zhitong Finance App, Yingpai Pharmaceutical-B (07630) issued an announcement. The board of directors has decided to buy back the company's H shares from time to time on the Hong Kong Stock Exchange Limited open market in accordance with the general authorization granted to the company's directors at the annual shareholders' meeting held on June 25, 2026, for a total amount not exceeding HK$100 million (including transaction costs such as brokerage commissions and stamp duties).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.